Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Human Gene Therapy|December 25, 2009
Gene transfer vectors targeted to human prostate cancer: do we need better preclinical testing systems?Norman Maitland, Karen Chambers, Lindsay Georgopoulos, et al.
Plos One|February 2, 2013
Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell culturesDi Yu, Chuan Jin, Mohanraj Ramachandran, et al.
Cell Stem Cell|December 2, 2019
Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes MalignancyMatko Čančer, Sonja Hutter, Karl O Holmberg, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2021
Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirusAlessandra Iscaro, Christian Jones, Neil Forbes, et al.
The Journal of Pathology|October 26, 2018
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patientsYuan Xie, Anders Sundström, Naga P Maturi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma PatientsTina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, et al.
Molecular Cancer Research : MCR|August 28, 2016
Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient SurvivalSoumi Kundu, Anqi Xiong, Argyris Spyrou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and LeukemiaGunilla Enblad, Hannah Karlsson, Gustav Gammelgård, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN 1 M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Oncoimmunology|April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapyMaria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
Pageof 9